Reasoning with chemically induced dynamic phenotypes in whole-organism assays
在整个生物体分析中用化学诱导的动态表型进行推理
基本信息
- 批准号:9810003
- 负责人:
- 金额:$ 20.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-06-01 至 2021-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAddressAlgorithmic SoftwareAlgorithmsAppearanceAreaBiological AssayCellsChemical StructureChemicalsChemistryCoenzyme ACollectionComplexComputer softwareComputersDataData SetDatabasesDetectionDevelopmentDiseaseDrug TargetingDrug effect disorderDrug resistanceEpigenetic ProcessEtiologyExhibitsExposure toGenderGene Expression ProfilingGenerationsGeneticGraphHelminthsImageImage AnalysisIndividualIndustryMeasuresMethodsMiningMolecular Mechanisms of ActionMolecular TargetMotionNoiseOnline SystemsOutputOxidoreductaseParasitesPatternPharmaceutical PreparationsPharmacologic SubstancePharmacologyPhasePhenotypePlatyhelminthsPopulationPovertyPraziquantelProteomicsPublicationsQuantitative ReasoningResearchResearch PersonnelResistanceResourcesRiskSchistosomaSchistosome ParasiteSchistosomiasisScientistSeriesShapesStructureStructure-Activity RelationshipSystems DevelopmentTechniquesTherapeuticTimeTranslatingWhole OrganismWorld Health Organizationalgorithmic methodologiesbasedata resourcedesigndisorder controldrug discoveryhigh dimensionalityinnovationinterestmetabolomicsmulticatalytic endopeptidase complexnovelnovel therapeuticsphenomephenotypic dataresponsescreeningsmall moleculesoftware developmentsoftware systemstechnology developmenttime usetoolweb services
项目摘要
ABSTRACT
Schistosomiasis, caused by a parasitic flatworm, is a disease of the poor. It infects over 200 million people worldwide and
places another 800 million at risk. Current treatment and control of this disease relies on just one drug, praziquantel (PZQ)
- a precarious situation should drug resistance emerge. The therapeutic profile of PZQ is also not ideal. The World Health
Organization has therefore declared schistosomiasis a disease for which new therapies are urgently needed.
Drug discovery for schistosomiasis in particular (and helmintic diseases in general) is traditionally based on
phenotypic screening, whereby the parasite(s) are exposed to compounds and their systemic responses, such as changes in
shape, appearance, and motion, are analyzed to identify hits. Analyzing the temporally varying, high-dimensional, and
information-rich output from phenotypic screening of a complex macroparasite is, however, non-trivial. This fact is
underlined by the complete absence of any database(s) or analysis tools for disease-causing helminths that would allow
analysis and reasoning with dynamic phenotypic data. To address this need, we formulate the following two aims:
Under Aim 1, we propose to develop the first quantitative and publicly available database of the schistosome’s time-
varying response to chemical probes. The database will support content-based querying of dynamic phenotypes using
time-series matching. The information in this database will underpin structure-activity relationship (SAR) studies with the
drug targets and associated small molecule chemistries that we have validated. This phenotypic record will also aid
understanding of the molecular mechanism of action (MMoA) of various chemistries and serve as a reference for
phenotypes elicited using other compounds by researchers worldwide.
Under Aim 2, we will develop algorithmic methods for analyzing the time-varying phenotypic responses of the
schistosome parasite. These methods will allow scientists to match, compare, cluster, and quantitatively reason-with
dynamic (i.e. temporally varying) phenotypes. In particular, scientists will be able to: (1) objectively compare phenotypic
responses of parasites to identify similar effects, even when they occur due to structurally distinct compounds, (2) relate
phenotypic effects observed in different studies conducted under varying conditions, (3) stratify the phenotypic variability
within and across parasite populations, and (4) prioritize compounds based on quantitative reasoning with dynamic and
complex phenotypic responses.
Results from both aims will be made freely available to biologists worldwide through a public database and software
developed by us. Our proposal constitutes an innovative point of progress in (a) developing algorithmic methods and
datasets for reasoning-with and understanding the phenome of the etiological agent of schistosomiasis and leveraging it
for drug discovery and (b) establishing a rigorous analysis framework and publicly available resources that can be applied
to other complex disease-causing macroparasites.
摘要
血吸虫病是由寄生的扁形虫引起的,是穷人的一种疾病。它感染了全世界超过2亿人,
又有8亿人处于危险之中目前对该病的治疗和控制仅依赖于一种药物吡喹酮(PZQ)
- 一旦出现抗药性,情况将岌岌可危。PZQ的治疗概况也不理想。世界卫生
因此,世界卫生组织宣布血吸虫病是一种急需新疗法的疾病。
特别是血吸虫病(以及一般的蠕虫病)的药物发现传统上是基于
表型筛选,由此使寄生虫暴露于化合物及其全身反应,如
形状、外观和运动被分析以识别命中。分析时变的、高维的、
然而,来自复杂大型寄生虫的表型筛选的信息丰富的输出是不平凡的。这一事实
强调指出,完全没有任何数据库或分析工具,
动态表型数据的分析和推理。为了满足这一需要,我们制定了以下两个目标:
在目标1下,我们建议开发第一个定量和公开可用的数据库,以了解人类的时间-
对化学探针的不同反应。该数据库将支持基于内容的动态表型查询,
时间序列匹配该数据库中的信息将支持结构-活性关系(SAR)研究,
我们已经验证的药物靶点和相关的小分子化学。这种表型记录也将有助于
了解各种化学物质的分子作用机制(MMoA),并作为
全世界的研究人员使用其他化合物引发的表型。
根据目标2,我们将开发算法方法,用于分析患者的时变表型反应。
可怕的寄生虫这些方法将使科学家能够匹配,比较,聚类和定量推理,
动态(即随时间变化的)表型。特别是,科学家将能够:(1)客观地比较表型
寄生虫的反应,以确定类似的影响,即使他们发生由于结构不同的化合物,(2)有关
在不同条件下进行的不同研究中观察到的表型效应,(3)对表型变异进行分层
在寄生虫种群内和跨寄生虫种群,以及(4)基于动态和动态的定量推理对化合物进行优先排序,
复杂的表型反应。
这两个目标的结果将通过公共数据库和软件免费提供给全世界的生物学家
由我们开发。我们的建议构成了一个创新点的进展,在(a)发展算法的方法,
用于推理和理解血吸虫病病原体的表型并利用它的数据集
(B)建立严格的分析框架和可应用的公共资源
其他复杂的致病大型寄生虫。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Conor Caffrey其他文献
Conor Caffrey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Conor Caffrey', 18)}}的其他基金
The catalytic core of the proteasome as a drug target to treat Human African Trypanosomiasis
蛋白酶体的催化核心作为治疗非洲人类锥虫病的药物靶点
- 批准号:
10511408 - 财政年份:2022
- 资助金额:
$ 20.48万 - 项目类别:
The catalytic core of the proteasome as a drug target to treat Human African Trypanosomiasis
蛋白酶体的催化核心作为治疗非洲人类锥虫病的药物靶点
- 批准号:
10677879 - 财政年份:2022
- 资助金额:
$ 20.48万 - 项目类别:
Exploring statins as a small molecule therapy for treatment of schistosomiasis
探索他汀类药物作为治疗血吸虫病的小分子疗法
- 批准号:
8569887 - 财政年份:2013
- 资助金额:
$ 20.48万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 20.48万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 20.48万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 20.48万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 20.48万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 20.48万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 20.48万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 20.48万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 20.48万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 20.48万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 20.48万 - 项目类别:
Research Grant














{{item.name}}会员




